• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于自动磁共振成像的神经胶质瘤分级、异柠檬酸脱氢酶(IDH)突变及1p19q共缺失分割与预测流程

Automated MRI based pipeline for segmentation and prediction of grade, IDH mutation and 1p19q co-deletion in glioma.

作者信息

Decuyper Milan, Bonte Stijn, Deblaere Karel, Van Holen Roel

机构信息

Medical Image and Signal Processing (MEDISIP), Ghent University, Ghent, Belgium.

Medical Image and Signal Processing (MEDISIP), Ghent University, Ghent, Belgium.

出版信息

Comput Med Imaging Graph. 2021 Mar;88:101831. doi: 10.1016/j.compmedimag.2020.101831. Epub 2020 Nov 27.

DOI:10.1016/j.compmedimag.2020.101831
PMID:33482430
Abstract

In the WHO glioma classification guidelines grade (glioblastoma versus lower-grade glioma), IDH mutation and 1p/19q co-deletion status play a central role as they are important markers for prognosis and optimal therapy planning. Currently, diagnosis requires invasive surgical procedures. Therefore, we propose an automatic segmentation and classification pipeline based on routinely acquired pre-operative MRI (T1, T1 postcontrast, T2 and/or FLAIR). A 3D U-Net was designed for segmentation and trained on the BraTS 2019 training dataset. After segmentation, the 3D tumor region of interest is extracted from the MRI and fed into a CNN to simultaneously predict grade, IDH mutation and 1p19q co-deletion. Multi-task learning allowed to handle missing labels and train one network on a large dataset of 628 patients, collected from The Cancer Imaging Archive and BraTS databases. Additionally, the network was validated on an independent dataset of 110 patients retrospectively acquired at the Ghent University Hospital (GUH). Segmentation performance calculated on the BraTS validation set shows an average whole tumor dice score of 90% and increased robustness to missing image modalities by randomly excluding input MRI during training. Classification area under the curve scores are 93%, 94% and 82% on the TCIA test data and 94%, 86% and 87% on the GUH data for grade, IDH and 1p19q status respectively. We developed a fast, automatic pipeline to segment glioma and accurately predict important (molecular) markers based on pre-therapy MRI.

摘要

在世界卫生组织的胶质瘤分类指南(胶质母细胞瘤与低级别胶质瘤)中,异柠檬酸脱氢酶(IDH)突变和1p/19q共缺失状态起着核心作用,因为它们是预后和优化治疗方案规划的重要标志物。目前,诊断需要侵入性手术操作。因此,我们提出了一种基于常规获取的术前磁共振成像(MRI)(T1加权像、T1加权增强像、T2加权像和/或液体衰减反转恢复序列像)的自动分割和分类流程。设计了一个3D U-Net用于分割,并在BraTS 2019训练数据集上进行训练。分割后,从MRI中提取3D肿瘤感兴趣区域,并将其输入到一个卷积神经网络(CNN)中,以同时预测级别、IDH突变和1p19q共缺失。多任务学习能够处理缺失标签的情况,并在从癌症成像存档库和BraTS数据库收集的628例患者的大型数据集中训练一个网络。此外,该网络在根特大学医院(GUH)回顾性获取的110例患者的独立数据集上进行了验证。在BraTS验证集上计算的分割性能显示,整个肿瘤的平均骰子系数得分达到90%,并且通过在训练期间随机排除输入MRI,提高了对缺失图像模态的鲁棒性。在TCIA测试数据上,级别、IDH和1p19q状态的曲线下面积分类得分分别为93%、94%和82%,在GUH数据上分别为94%、86%和87%。我们开发了一种快速、自动的流程来分割胶质瘤,并基于治疗前的MRI准确预测重要的(分子)标志物。

相似文献

1
Automated MRI based pipeline for segmentation and prediction of grade, IDH mutation and 1p19q co-deletion in glioma.基于自动磁共振成像的神经胶质瘤分级、异柠檬酸脱氢酶(IDH)突变及1p19q共缺失分割与预测流程
Comput Med Imaging Graph. 2021 Mar;88:101831. doi: 10.1016/j.compmedimag.2020.101831. Epub 2020 Nov 27.
2
Machine learning reveals multimodal MRI patterns predictive of isocitrate dehydrogenase and 1p/19q status in diffuse low- and high-grade gliomas.机器学习揭示了可预测弥漫性低级别和高级别神经胶质瘤异柠檬酸脱氢酶和 1p/19q 状态的多模态 MRI 模式。
J Neurooncol. 2019 Apr;142(2):299-307. doi: 10.1007/s11060-019-03096-0. Epub 2019 Jan 19.
3
A novel fully automated MRI-based deep-learning method for classification of IDH mutation status in brain gliomas.一种新的基于全自动化 MRI 的深度学习方法,用于脑胶质瘤中 IDH 突变状态的分类。
Neuro Oncol. 2020 Mar 5;22(3):402-411. doi: 10.1093/neuonc/noz199.
4
The Diagnostic Value of Conventional MRI and CT Features in the Identification of the IDH1-Mutant and 1p/19q Co-Deletion in WHO Grade II Gliomas.常规 MRI 和 CT 特征对 IDH1 突变和 1p/19q 共缺失型 WHO Ⅱ级胶质瘤的诊断价值。
Acad Radiol. 2021 Jul;28(7):e189-e198. doi: 10.1016/j.acra.2020.03.008. Epub 2020 Apr 28.
5
Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II-III diffuse gliomas.世界卫生组织II - III级弥漫性胶质瘤组织学和基因亚型中的灌注及扩散磁共振成像特征
J Neurooncol. 2017 Aug;134(1):177-188. doi: 10.1007/s11060-017-2506-9. Epub 2017 May 25.
6
The T2-FLAIR-mismatch sign as an imaging biomarker for IDH and 1p/19q status in diffuse low-grade gliomas: a systematic review with a Bayesian approach to evaluation of diagnostic test performance.T2-FLAIR 错配征象作为弥漫性低级别胶质瘤 IDH 和 1p/19q 状态的影像学生物标志物:一项基于贝叶斯方法评估诊断试验性能的系统评价。
Neurosurg Focus. 2019 Dec 1;47(6):E13. doi: 10.3171/2019.9.FOCUS19660.
7
Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion.IDH 1/2 突变且无 1p/19q 共缺失的 WHO Ⅲ级胶质瘤患者行全切除的影响
J Neurooncol. 2016 Sep;129(3):505-514. doi: 10.1007/s11060-016-2201-2. Epub 2016 Jul 11.
8
Reproducible imaging-based prediction of molecular subtype and risk stratification of gliomas across different experience levels using a structured reporting system.基于可重复成像的预测,使用结构化报告系统在不同经验水平下对脑胶质瘤的分子亚型和风险分层进行预测。
Eur Radiol. 2021 Oct;31(10):7374-7385. doi: 10.1007/s00330-021-08015-4. Epub 2021 Aug 10.
9
Two-Stage Training Framework Using Multicontrast MRI Radiomics for Mutation Status Prediction in Glioma.基于多对比度 MRI 放射组学的两阶段训练框架用于预测脑胶质瘤的突变状态。
Radiol Artif Intell. 2024 Jul;6(4):e230218. doi: 10.1148/ryai.230218.
10
Fully automated hybrid approach to predict the IDH mutation status of gliomas via deep learning and radiomics.基于深度学习和放射组学的全自动混合方法预测脑胶质瘤 IDH 突变状态。
Neuro Oncol. 2021 Feb 25;23(2):304-313. doi: 10.1093/neuonc/noaa177.

引用本文的文献

1
AI-Driven Innovations in Neuroradiology and Neurosurgery: Scoping Review of Current Evidence and Future Directions.人工智能驱动的神经放射学与神经外科创新:当前证据与未来方向的范围综述
Cancers (Basel). 2025 Aug 11;17(16):2625. doi: 10.3390/cancers17162625.
2
Bridging the clinical gap: Confidence informed IDH prediction in brain gliomas using MRI and deep learning.弥合临床差距:利用磁共振成像(MRI)和深度学习实现脑胶质瘤中异柠檬酸脱氢酶(IDH)预测的信心告知
Neurooncol Adv. 2025 Jul 25;7(1):vdaf142. doi: 10.1093/noajnl/vdaf142. eCollection 2025 Jan-Dec.
3
Diagnostic performance of deep learning for predicting glioma isocitrate dehydrogenase and 1p/19q co-deletion in MRI: a systematic review and meta-analysis.
深度学习在磁共振成像中预测胶质瘤异柠檬酸脱氢酶和1p/19q共缺失的诊断性能:一项系统评价和荟萃分析
Eur Radiol. 2025 Aug 16. doi: 10.1007/s00330-025-11898-2.
4
A multitask framework based on CA-EfficientNetV2 for the prediction of glioma molecular biomarkers.一种基于CA-EfficientNetV2的多任务框架,用于预测胶质瘤分子生物标志物。
Front Neurol. 2025 Jul 18;16:1609594. doi: 10.3389/fneur.2025.1609594. eCollection 2025.
5
Zinc finger protein 800 (ZNF800) promotes proliferation and migration of lower-grade glioma and is associated with immune infiltration.锌指蛋白800(ZNF800)促进低级别胶质瘤的增殖和迁移,并与免疫浸润相关。
PLoS One. 2025 Jul 11;20(7):e0324426. doi: 10.1371/journal.pone.0324426. eCollection 2025.
6
MRI-derived deep learning models for predicting 1p/19q codeletion status in glioma patients: a systematic review and meta-analysis of diagnostic test accuracy studies.用于预测胶质瘤患者1p/19q共缺失状态的磁共振成像衍生深度学习模型:诊断试验准确性研究的系统评价和荟萃分析
Neuroradiology. 2025 May 15. doi: 10.1007/s00234-025-03631-z.
7
MRI transformer deep learning and radiomics for predicting IDH wild type TERT promoter mutant gliomas.用于预测异柠檬酸脱氢酶野生型、端粒酶逆转录酶启动子突变型胶质瘤的磁共振成像变压器深度学习与放射组学
NPJ Precis Oncol. 2025 Mar 27;9(1):89. doi: 10.1038/s41698-025-00884-y.
8
Glioma subtype prediction based on radiomics of tumor and peritumoral edema under automatic segmentation.基于肿瘤和瘤周水肿自动分割的影像组学预测胶质瘤亚型。
Sci Rep. 2024 Nov 10;14(1):27471. doi: 10.1038/s41598-024-79344-9.
9
Non-invasive classification of IDH mutation status of gliomas from multi-modal MRI using a 3D convolutional neural network.使用三维卷积神经网络从多模态磁共振成像对胶质瘤的异柠檬酸脱氢酶(IDH)突变状态进行无创分类。
Proc SPIE Int Soc Opt Eng. 2023 Feb;12465. doi: 10.1117/12.2651391. Epub 2023 Apr 7.
10
Radiogenomics: bridging the gap between imaging and genomics for precision oncology.放射基因组学:弥合影像学与基因组学之间的差距,实现精准肿瘤学。
MedComm (2020). 2024 Sep 9;5(9):e722. doi: 10.1002/mco2.722. eCollection 2024 Sep.